- Poster presentation
- Open Access
PB.36: Double reporting of patients discharged from the assessment clinic: the North Lancashire and South Cumbria experience
© Mataka; licensee BioMed Central Ltd. 2013
- Published: 8 November 2013
- Cancer Research
- Assessment Clinic
- Ductal Carcinoma
- Screening Programme
There are currently no available guidelines regarding the double reporting of patients discharged from the assessment clinic back to the screening programme.
A retrospective audit of patients who were referred for arbitration following discordant double reporting of patients discharged from the assessment clinic was performed. This was performed over a 2-year period from May 2011 to May 2013. The available imaging was reviewed. The outcome of arbitration was documented. The morphology of the lesion, whether a second assessment was required and outcome of the second assessment were also recorded.
A total of 4,445 patients were assessed in our breast unit. All patients discharged back to the screening programme following assessment were double reported at the end of the clinic. Thirteen (0.29%) patients were referred for arbitration. The morphology of the lesions was as follows: asymmetric density (n = 8), microcalcification (n = 4) and distortion (n = 1). Following arbitration, nine patients were discharged back to the screening programme. The remaining four patients underwent a second assessment. All patients who underwent a second assessment had a biopsy performed. Three of these patients were discharged following a benign biopsy result. The remaining patient was diagnosed with a grade I invasive ductal carcinoma.
The number of patients requiring a second assessment is very small (0.09%), limiting the psychological impact on our patients. Asymmetric densities are the most common abnormality resulting in referral for arbitration. Double reporting of assessment clinic patients discharged back to the screening programme is now standard practice in our unit.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.